In a filing, Incyte Corp. revealed its EVP & Chief Medical Officer Stein Steven H unloaded Company’s shares for reported $0.7 million on Aug 12 ’24. In the deal valued at $60.63 per share,11,608 shares were sold. As a result of this transaction, Stein Steven H now holds 90,011 shares worth roughly $5.77 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, STEVEN STEIN bought 11,608 shares, generating $703,771 in total proceeds.
Before that, Iyengar Vijay K sold 15,571 shares. Incyte Corp. shares valued at $1,089,970 were divested by the EVP, GMAPPS at a price of $70.00 per share. As a result of the transaction, Iyengar Vijay K now holds 36,701 shares, worth roughly $2.35 million.
BMO Capital Markets downgraded its Incyte Corp. [INCY] rating to an Underperform from a a Market perform in a research note published on July 02, 2024; the price target was decreased to $48 from $52. A number of analysts have revised their coverage, including Deutsche Bank’s analysts, who began to cover the stock in late May with a ‘”a Hold”‘ rating. Cantor Fitzgerald began covering INCY with “Neutral” recommendation on April 23, 2024. Jefferies started covering the stock on February 23, 2024. It rated INCY as “a Buy”.
Price Performance Review of INCY
On Friday, Incyte Corp. [NASDAQ:INCY] saw its stock jump 1.78% to $64.14. Over the last five days, the stock has gained 3.19%. Incyte Corp. shares have risen nearly 2.15% since the year began. Nevertheless, the stocks have fallen -0.79% over the past one year. While a 52-week high of $70.36 was reached on 07/25/24, a 52-week low of $50.27 was recorded on 04/30/24. SMA at 50 days reached $62.99, while 200 days put it at $59.02.
Levels Of Support And Resistance For INCY Stock
The 24-hour chart illustrates a support level at 63.31, which if violated will result in even more drops to 62.47. On the upside, there is a resistance level at 64.72. A further resistance level may holdings at 65.29. The Relative Strength Index (RSI) on the 14-day chart is 54.70, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.52, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 16.15%. Stochastics%K at 74.57% indicates the stock is a holding.
How much short interest is there in Incyte Corp.?
A steep rise in short interest was recorded in Incyte Corp. stocks on 2024-07-31, dropping by -4.78 million shares to a total of 12.15 million shares. Yahoo Finance data shows the prior-month short interest on 2024-06-28 was 16.93 million shares. There was a decline of -39.37%, which implies that there is a negative sentiment for the stock.
